SOPHiA UNITY: Accelerating Precision Oncology through Collective Intelligence

When we founded SOPHiA GENETICS , we had a dream: to harness the power of patient data to transform healthcare. Today, with the launch of SOPHiA UNITY, that dream is becoming a reality.??

Our vision is to build a future in which each patient has equal access to world-class care.? ?

SOPHiA UNITY is more than tech advancement. It is the culmination of our efforts to empower hospitals and healthcare professionals to define what drives cancer. We have always aimed to track longitudinally how patients are treated, with the desire to enable the prediction of the most effective treatments for future patients.

SOPHiA UNITY accelerates this vision, moving beyond genomics to a multimodal, real-time, data-driven approach that breaks down information silos across modalities and institutions.?

Accelerate Drug Development

Time is critical in the pharmaceutical industry. The lengthy process of drug development, clinical trials, and regulatory approval delays the availability of treatments. SOPHiA UNITY aims to address it by integrating diverse data sources—genomic, clinical, imaging, and more—into a comprehensive platform that speeds up every stage of research and development.?

A Collective Intelligence Network?

SOPHiA UNITY is designed to bring together leading healthcare institutions to advance cancer research, drug development, and data-driven patient care.??

By aggregating and analyzing complex real-world data through SOPHiA CarePath?, our multimodal module on the SOPHiA DDM? Platform, we provide harmonized and curated insights using our advanced AI-based technology and proprietary algorithms.?

Real-World Impact?

For instance, our recent expansion to Nigeria is significant due to the high prevalence of the MSI (Microsatellite Instability) biomarker in colorectal cancer, which is nearly 30%, according to MSKCC research. ??

Testing these patients would not only benefit them directly but would also help the patients of tomorrow and expand the pool of participants for clinical trials, accelerating drug development and improving patient outcomes globally. This means faster, more targeted, and more affordable treatments reach the market sooner.?

Joining Forces for a Better Future?

Our collaboration with 纪念斯隆-凯特琳癌症中心 (MSK) started at the end of 2022. Since then, we have made tremendous progress, leveraging MSK's extensive patient data to enhance our smart analytics capabilities.??

As SOPHiA UNITY's first member, MSK exemplifies the type of top-tier institution joining our network. Together, we will generate insights that not only transform healthcare but also pave the way for breakthroughs that benefit future generations.?

As a father and CEO, I see the importance of time management and efficient collaboration. Just as my daughter and her classmates demonstrated in a prize-winning video about environmental conservation, small and consistent actions can lead to significant impacts. ?

By working together within SOPHiA UNITY, we are taking steps toward transforming healthcare.??

Invitation to Collaborate

Leading academic cancer centers interested in joining this pioneering collective intelligence network can gather and implement insights locally, contributing to a global movement towards precision oncology.

Connect with SOPHiA GENETICS on LinkedIn or on our website if you would like to collaborate.??

Together, we aim to improve the lives of patients everywhere.?